Graf Akcie INO (Inovio Pharmaceuticals Inc). Diskuze k akciím INO. Aktuální informace INO.

Základní informace o společnosti Inovio Pharmaceuticals Inc (Akcie INO)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 1.5B
Hodnota podniku (EV) 1.22B
Tržby 6.461M
EBITDA -212.53
Zisk -141.71
Růst v tržbách Q/Q 2.11 %
Růst v tržbách Y/Y 135.72 %
P/E (Cena vůči ziskům) N/A
Forward P/E N/A
EV/Sales 189.49
EV/EBITDA N/A
EV/EBIT N/A
PEG N/A
Price/Sales 232.66
P/FCF N/A
Price/Book 3.26
Účetní hodnota na akcii 2.20
Hotovost na akcii 1.96
FCF vůči ceně -17.20 %
Počet zaměstnanců 262
Tržba na zaměstnance 24.659k
Profit margin -2,245.39 %
Operating margin -3,117.70 %
Gross margin 100.00 %
EBIT margin -2,131.00 %
EBITDA margin -3,289.53 %
EPS - Zisk na akcii N/A
EPS - Kvartální růst -53.01 %
EPS - Očekávaný růst příští rok -400.00 %
Return on assets -25.48 %
Return on equity -30.23 %
ROIC -46.27 %
ROCE -25.49 %
Dluhy/Equity 0.17
Čistý dluh/EBITDA 7.20
Current ratio 10.48
Quick Ratio 10.48
Volatilita 4.87
Beta 0.52
RSI 46.79
Cílová cena analytiků 14
Známka akcie (dle analytiků) 2.75
Insider ownership 1.66 %
Institutional ownership 36.56 %
Počet akcií 210.357M
Procento shortovaných akcií 22.69 %
Short ratio 8.10 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 1998
Země United States

Finanční výsledky akcie INO

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$4.112$30.482$42.22$35.368$40.572$10.457
Cost Of Goods Sold------
Gross Profit$4.112$30.482$42.22$35.368$40.572$10.457
Research And Development Expenses$88.017$95.258$98.573$88.712$57.792$34.095
SG&A Expenses$27.203$29.315$28.29$23.892$18.064$15.858
Other Operating Income Or Expenses--$1$1$1-
Operating Expenses$115.221$124.573$125.863$111.604$74.856$49.953
Operating Income$-111.109$-94.091$-83.643$-76.236$-34.284$-39.496
Total Non-Operating Income/Expense$-9.701$-0.707$-4.563$2.496$3.083$3.356
Pre-Tax Income$-120.809$-94.798$-88.206$-73.74$-31.201$-36.14
Income Taxes$-0.257$2.17--$-2.098-
Income After Taxes$-120.552$-96.968$-88.206$-73.74$-29.103$-36.14
Other Income------
Income From Continuous Operations$-120.552$-96.968$-88.206$-73.74$-29.103$-36.14
Income From Discontinued Operations------
Net Income$-119.359$-96.968$-88.206$-73.74$-29.188$-36.122
EBITDA$-105.59$-89.022$-79.854$-72.884$-32.017$-37.872
EBIT$-111.109$-94.091$-83.643$-76.236$-34.284$-39.496
Basic Shares Outstanding999382736859
Shares Outstanding999382736859
Basic EPS$-1.21$-1.05$-1.08$-1.01$-0.43$-0.61
EPS - Earnings Per Share$-1.21$-1.05$-1.09$-1.01$-0.44$-0.64
# 2020 2019 2018 2017 2016 2015
Current Ratio2.94482.48773.90792.84325.46147.0249
Long-term Debt / Capital0.9344-----
Debt/Equity Ratio14.2507-----
Gross Margin100100100100100100
Operating Margin-2702.102-308.6787-198.1116-215.5484-84.5007-377.7072
EBIT Margin-2702.102-308.6787-198.1116-215.5484-84.5007-377.7072
EBITDA Margin-2567.897-292.0481-189.1375-206.0703-78.9126-362.1785
Pre-Tax Profit Margin-2938.015-310.9978-208.919-208.4924-76.9016-345.6148
Net Profit Margin-2902.754-318.1161-208.919-208.4924-71.9401-345.4387
Asset Turnover0.02860.23250.22550.20360.18970.0793
Inventory Turnover Ratio------
Receiveable Turnover2.02357.51726.50562.13455.53283.729
Days Sales In Receivables180.383148.555256.1057171.000365.970697.8826
ROE - Return On Equity-2230.42-111.4158-61.9037-59.7676-16.542-32.4018
Return On Tangible Equity1369.539-135.1301-70.0236-70.071-17.9743-37.3935
ROA - Return On Assets-83.7447-73.9573-47.1086-42.451-13.6096-27.4235
ROI - Return On Investment-146.2514-111.4158-61.9036-59.7676-16.542-32.4018
Book Value Per Share0.05330.89521.57691.66592.43611.8363
Operating Cash Flow Per Share-0.1964-0.02320.0828-0.67250.3201-0.1683
Free Cash Flow Per Share-0.18390.08-0.0055-0.66920.3026-0.1876

Porovnání s konkurencí: Akcie INO

Společnost P/E PEG Růst v tržbách (roční) Růst v EPS Return on equity P/B Profit margin
INO N/A N/A 135.72 % -400.00 % -30.23 % 3.26 -2,245.39 %
Akcie ARWR N/A N/A -12.95 % -79.17 % -28.00 % 15.06 -96.09 %
Akcie CBLI N/A N/A N/A % N/A % -83.71 % -16.57 -912.16 %
Akcie DRRX N/A N/A -88.00 % 0.00 % -42.18 % 6.81 -1.93 %
Akcie GSK 16.60 3.36 N/A % -14.00 % 29.69 % 4.85 16.86 %
Akcie GILD 16.42 0.56 20.13 % -20.85 % 27.79 % 4.69 0.50 %
Akcie JNJ 23.93 1.67 10.79 % 7.27 % 27.01 % 6.67 17.82 %
Akcie MRK 35.60 1.38 2.87 % 13.14 % 19.42 % 7.90 14.72 %
Akcie PFE 17.66 1.97 4.96 % 50.00 % 19.81 % 3.72 22.95 %

Nedávné obchody insiderů: Akcie INO

Jméno Obchod Cena Objem
Wendy L Yarno
Director
Option
5 Dec 2020
$12.60 $51,534
David B. Weiner
Director
Option
15 Dec 2020
$4.56 $79,800
Peter Kies
CFO
Option
15 Dec 2020
$2.27 $45,400
Lota S. Zoth
Director
Option
3 Jan 2021
$8.85 $36,197
Simon X Benito
Director
Option
4 Jan 2021
$3.56 $9,790
Jay Shepard
Director
Option
15 Jan 2021
$9.66 $41,287
Peter Kies
CFO
Option
15 Jan 2021
$4.56 $136,800
Jacqueline Elizabeth Shea
Chief Operating Officer
Option
27 Jan 2021
$3.62 $280,999
Jacqueline Elizabeth Shea
Chief Operating Officer
Prodej
1 Feb 2021
$15.05 $426,457
Jong Joseph Kim
Chief Executive Officer
Prodej
1 Feb 2021
$14.71 $2,390,375
Simon X Benito
Director
Option
16 Feb 2021
$3.56 $7,120
Wendy L Yarno
Director
Option
5 Dec 2020
$12.60 $51,534
David B. Weiner
Director
Option
15 Dec 2020
$4.56 $79,800
Peter Kies
CFO
Option
15 Dec 2020
$2.27 $45,400
Lota S. Zoth
Director
Option
3 Jan 2021
$8.85 $36,197
Simon X Benito
Director
Option
4 Jan 2021
$3.56 $9,790
Jay Shepard
Director
Option
15 Jan 2021
$9.66 $41,287
Peter Kies
CFO
Option
15 Jan 2021
$4.56 $136,800
Jacqueline Elizabeth Shea
Chief Operating Officer
Option
27 Jan 2021
$3.62 $280,999
Jacqueline Elizabeth Shea
Chief Operating Officer
Prodej
1 Feb 2021
$15.05 $426,457
Jong Joseph Kim
Chief Executive Officer
Prodej
1 Feb 2021
$14.71 $2,390,375
Simon X Benito
Director
Option
16 Feb 2021
$3.56 $7,120

Diskuze k akciím INO